(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 8.2% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.86%.
Mckesson's revenue in 2025 is $377,595,000,000.On average, 6 Wall Street analysts forecast MCK's revenue for 2026 to be $50,894,674,786,174, with the lowest MCK revenue forecast at $50,669,337,158,974, and the highest MCK revenue forecast at $51,198,967,023,828. On average, 5 Wall Street analysts forecast MCK's revenue for 2027 to be $54,999,345,699,738, with the lowest MCK revenue forecast at $54,346,016,551,121, and the highest MCK revenue forecast at $55,484,597,078,935.
In 2028, MCK is forecast to generate $59,578,887,617,365 in revenue, with the lowest revenue forecast at $58,278,205,243,908 and the highest revenue forecast at $61,580,010,474,593.